Who
Kevin Lee
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Bicycle Therapeutics.
In numbers
- Trades disclosed
- 133
- Buys
- 0
- Sells
- 53
- Bought
- $0
- Sold
- $9.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 May 2019
- Last trade
- 5 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $5,8481,638 at $3.57 | filing |
| 2 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K6,167 at $3.47 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,4861,737 at $4.31 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,4861,737 at $4.31 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $25K5,905 at $4.27 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $25K5,905 at $4.27 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $8,6661,716 at $5.05 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $8,6661,716 at $5.05 | filing |
| 2 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $29K5,967 at $4.91 | filing |
| 2 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $29K5,967 at $4.91 | filing |
| 5 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $71K10,989 at $6.46 | filing |
| 5 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $71K10,989 at $6.46 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —165,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $70K10,325 at $6.80 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —330,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —330,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —165,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $70K10,325 at $6.80 | filing |
| 3 Oct 2025filed 6 Oct 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $27K3,231 at $8.41 | filing |
| 2 Oct 2025filed 6 Oct 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $19K2,263 at $8.40 | filing |
News
'Old Money' Has Stronger Bitcoin 'Diamond Hands': Kevin Leecointelegraph.com · 7 Oct 2026Bicycle Therapeutics (NASDAQ:BCYC) Stock: Insider Kevin Lee Sells 6,167 Sharesthemarketsdaily.com · 6 Oct 2026
2 headlines in the last 90 days name Kevin Lee; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.